We take a look at the hallmarks of aging that lead to age-related ill health.
A small clinical trial, which was conducted by a team of researchers led by Dr. Greg Fahy, has shown for the first time in humans that reversing biological age may be possible.
Dr. David Sinclair, a Professor of Genetics at Harvard Medical School, is one of the most well-known researchers in the field of rejuvenation well known for his work with NAD+ and aging.
We collaborate with Ryan O’Shea from Future Grind and he presents the Rejuvenation Roundup Podcast, a monthly digest of the latest rejuvenation biotechnology news.
We collaborate with popular Youtube channels to produce fun and educational shows about aging research. This video was made in collaboration with popular science channel – Kurzgesagt and has been seen by over 5 million people to date.
To date, we have raised over $360,000 for research since we launched our aging research crowdfunding platform – Lifespan.io.
We have helped the David Sinclair Lab at Harvard University to raise funding for the NAD+ Mouse project, a project that explores the metabolic drivers of aging and could have ramifications for human aging and health in the near future.
The SENS Research Foundation has successfully funded three projects on Lifespan.io and as a result is pioneering new approaches to treating mitochondria disorders and new ways to combat cancer.
A functional aging diagnostic system that was developed thanks to the support of the community. This unit allows you to measure how well you are aging using a series of scientifically supported biomarkers of aging that measure your level of function.
Thanks to the support of the community this cruelty free app allows researchers to estimate the age of lab mice using the power of deep learning without the need for invasive tests.
Thanks to the support of the community the MitoSENS campaign funded on Lifespan.io has published successful results for their mitochondrial repair approach. This is the first demonstration that creating copies of mitochondrial genes in the cell nucleus may be a potential way to address mitochondrial DNA damage which is a root cause of various age-related diseases and other conditions.
The Longevity Investor Network is a LEAF initiative to bring investors and promising, aging-focused biotech startups together. The network is organized by LEAF board members and meets once a month to listen to presentation pitches from new companies seeking funding.